JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use

被引：5
|
作者：
Guilpain, Philippe [1 ,2 ,3 ]
机构：
[1] St Eloi Hosp, Dept Internal Med & Multiorgan Dis, Local Referral Ctr Syst & Autoimmune Dis, Montpellier, France
[2] Univ Montpellier, Fac Med, Montpellier, France
[3] St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Inserm U1183, Montpellier, France
来源：
RHEUMATOLOGY | 2023年 / 62卷 / 04期
关键词：
SAFETY;
D O I：
10.1093/rheumatology/keac592
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1368 / 1369
页数：2
相关论文
共 50 条
  • [31] Opioid Drug Use Prompts Clinical Guideline Development
    不详
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2009, 47 (04) : 10 - 11
  • [32] Use of biomarkers in ALS drug development and clinical trials
    Bakkar, Nadine
    Boehringer, Ashley
    Bowser, Robert
    BRAIN RESEARCH, 2015, 1607 : 94 - 107
  • [33] JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
    Szalus, Krzysztof
    Trzeciak, Magdalena
    Nowicki, Roman J.
    MICROORGANISMS, 2020, 8 (11) : 1 - 14
  • [34] Major pitfalls of protein kinase inhibitors prescription: A review of their clinical pharmacology for daily use
    Gougis, Paul
    Palmieri, Lola-Jade
    Funck-Brentano, Christian
    Paci, Angelo
    Flippot, Ronan
    Mir, Olivier
    Coriat, Romain
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 141 : 112 - 124
  • [35] LONG-TERM SAFETY OF CANAKINUMAB IN AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES-48-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Henes, J.
    Kortus-Goetze, B.
    Oommen, P.
    Pankow, A.
    Kallinich, T.
    Krickau, T.
    Schuetz, C.
    Horneff, G.
    Foeldvari, I.
    Rech, J.
    Weller-Heinemann, F.
    Janda, A.
    Hufnagel, M.
    Meier, F.
    Dressler, F.
    Borte, M.
    Andreica, I.
    Wasiliew, P.
    Fiene, M.
    Windschall, D.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1153 - 1153
  • [36] Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
    Castaneda-Estevez, Elisabet
    Vergara-Dangond, Cristina
    Steiner, Martina
    Paredes-Romero, Maria Beatriz
    Esteban-Vazquez, Ana
    Cobo-Ibanez, Tatiana
    Trives-Folguera, Laura
    Romero-Bogado, Maria Liz
    de la Camara-fernandez, Isabel
    Richi-Alberti, Patricia
    Acosta-Alfaro, Ana
    de la Osa-subtil, Iria
    Munoz-Fernandez, Santiago
    PHARMACEUTICALS, 2025, 18 (01)
  • [37] The congenital long QT syndromes from genotype to phenotype: clinical implications
    Schwartz, PJ
    JOURNAL OF INTERNAL MEDICINE, 2006, 259 (01) : 39 - 47
  • [38] Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors
    Castaneda Estevez, Elisabet
    Vergara Dangond, Cristina
    Steiner, Martina
    Paredes Romero, Maria Beatriz
    Esteban Vazquez, Ana
    Cobo Ibanez, Tatiana
    Trives Folguera, Laura
    Romero Bogado, Maria Liz
    De La Camara Fernandez, Isabel
    Richi Alberti, Patricia
    Acosta Alfaro, Ana Valeria
    De La Osa Subtil, Iria
    Munoz Fernandez, Santiago
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2119 - 2121
  • [39] The EU and sustainable development - The long road from Rio to Johannesburg
    Burchell, J
    Lightfoot, S
    EUROPE, GLOBALIZATION AND SUSTAINABLE DEVELOPMENT, 2004, : 168 - 185
  • [40] The Long Road to a New Short-Bowel Therapy: Teduglutide for Clinical Use
    Semrad, Carol E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) : 824 - 825
12345